Induction with Thymoglobin in high-risk renal transplant patients: beauty and the beast

Keyphrases

• High Risk 100%
• Host Immune Response 100%
• Renal Transplant Recipients 100%
• Immune Suppression 100%
• Antithymocyte Globulin 100%
• Induction Protocol 100%
• Treatment Choice 50%
• Patient Survival 50%
• Renal Transplantation 50%
• Acute Rejection 50%
• Alemtuzumab 50%
• Basiliximab 50%
• Perioperative Period 50%
• Induction Immunosuppression 50%
• Delayed Graft Function 50%
• Renal Failure Patients 50%
• Transplantation Immunology 50%
• Induction Regimen 50%
• Promising Strategies 50%
• Induction Agents 50%
• Graft Survival 50%

Immunology and Microbiology

• Monospecific Antibody 100%
• Immune System 100%
• Transplant Procedure 100%
• Anti-Thymocyte Globulin 100%
• Immunosuppression 50%
• Acute Graft Rejection 50%
• Alemtuzumab 50%
• Basiliximab 50%
• Histocompatibility 50%
• Kidney Transplantation 50%

Medicine and Dentistry

• Histocompatibility 33%